Claudia Menghetti

Claudia Menghetti

Auto-generated profile, based on publicly available information

Claudia Menghetti

Department of Neurosurgery, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Experimental Neurology
Verified
Journal Article
Closed access
GGGaia Giannicola
Gaia Giannicola
MRManuela Rosa
Manuela Rosa
DSDomenico Servello
Domenico Servello
CMClaudia Menghetti
Claudia Menghetti
GCGiorgio Carrabba
Giorgio Carrabba
Alberto PrioriAlberto Priori
Alberto Priori

9 September 2012 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
MPM. Porta
M. Porta
DSDomenico Servello
Domenico Servello
CZC. Zanaboni
C. Zanaboni
FAF. Anasetti
F. Anasetti
CMC. Menghetti
C. Menghetti
MRM. M. Robertson
M. M. Robertson

1 January 2013 in Neurosignals
Verified
Journal Article
Open access
PDF file
GGGaia Giannicola
Gaia Giannicola
MRManuela Rosa
Manuela Rosa
SMSara Marceglia
Sara Marceglia
ESEmma Scelzo
Emma Scelzo
LRLorenzo Rossi
Lorenzo Rossi
Alberto PrioriAlberto Priori
Alberto Priori
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation settings online so as to achieve better control over the clinical fluctuations in Parkinson's disease (PD). Local field potentials (LFPs) recorded from the subthalamic nucleus (STN) in PD patients show that levodopa and DBS modulate STN oscillations. Because previous research has shown that levodopa and DBS variably influence beta LFP activity (8-20 Hz), we designed this study to find out how they affect low-frequency (LF) oscillations (2-7 Hz). STN LFPs were recorded in 19 patients with PD during DBS, after levodopa medication, and during DBS and levodopa intake combined. We investigated the relationship between LF modulations, DBS duration and levodopa intake. We also studied whether LF power depended on disease severity, the patient's clinical condition and whether LF modulations were related to electrode impedances. LF power increased during DBS, after levodopa intake and under both experimental conditions combined. The LF power increase correlated with the levodopa-induced clinical improvement and the higher the electrode impedance, the greater was the LF power change. These data suggest that the LF band could be useful as a control neurosignal for developing novel adaptive DBS systems for patients with PD.

1 September 2013 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
PDF file
MSMarco Sassi
Marco Sassi
Edvin ZekajEdvin Zekaj
Edvin Zekaj
AGAlessandra Grotta
Alessandra Grotta
APAlberto Pollini
Alberto Pollini
APArmando Pellanda
Armando Pellanda
DSDomenico Servello
Domenico Servello

15 July 2009 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
FCFrancesco Costa
Francesco Costa
CMClaudia Menghetti
Claudia Menghetti
ACAndrea Cardia
Andrea Cardia
MFMaurizio Fornari
Maurizio Fornari
AOAlessandro Ortolina
Alessandro Ortolina

1 January 2014 in Surgical Neurology International
Verified
Journal Article
Open access
DSDomenico Servello
Domenico Servello
Edvin ZekajEdvin Zekaj
Edvin Zekaj
Christian SalehChristian Saleh
Christian Saleh
CMClaudia Menghetti
Claudia Menghetti
MPMauro Porta
Mauro Porta
Progressive supranuclear palsy (PSP) is a neurodegenerative disease due to mitochondrial dysfunction. The PSP syndrome presents generally with gait disorder, Parkinsonism, ophthalmoparesis and cognitive alteration. Few reports exist on deep brain stimulation (DBS) in patients with atypical Parkinsonism. The aim of our study was to evaluate further the potential role of DBS in PSP. We report three patients with PSP with long-term follow up undergoing DBS. Two patients had right peripedunculopontine nucleus (PPN) stimulation and one patient had simultaneous right PPN and bilateral globus pallidus internus DBS. DBS of the PPN alone or combined with globus pallidus internus (GPi) determined an improvement in gait and a reduction in falls sustained over time. Combined target stimulation (GPi-PPN) was correlated with better clinical outcome than single target (PPN) DBS for PSP. Although few data on DBS for PSP exist, reported clinical results are encouraging. DBS might be considered as an alternative therapeutic option for patients with PSP presenting with relevant gait imbalance and frequent falls, who fail to respond to pharmacological treatment. Larger cohorts with longer follow-ups are needed to evaluate more exhaustively the efficacy of DBS in PSP.